We are live on
!
Find out more
SNSE
Sensei Biotherapeutics
SNSE
SNSE
Delisted
SNSE was delisted on the 15th of June, 2026.
37 hedge funds and large institutions have $19.7M invested in Sensei Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
47% less capital invested
Capital invested by funds: $37.1M → $19.7M (-$17.3M)
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.51M | |
| 2 | +$316K | |
| 3 | +$250K | |
| 4 |
Two Sigma Investments
New York
|
+$215K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$160K |
Top Sellers
| 1 | -$1.3M | |
| 2 | -$1.28M | |
| 3 | -$519K | |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$394K |
| 5 |
MCCP
Mission Creek Capital Partners
San Francisco,
California
|
-$345K |